T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.81B |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.46B |
| 3 |
Accenture
ACN
|
+$1.23B |
| 4 |
Gilead Sciences
GILD
|
+$1.15B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06B |
| 3 |
Tesla
TSLA
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.72B |
| 5 |
Amazon
AMZN
|
+$1.59B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Columbia Financial
CLBK
$1.18B
| $175K | ﹤0.01% |
25,656
+2,415
| +10% | +$17K |
|
2677
Nektar Therapeutics
NKTR
$1.95B
| $175K | ﹤0.01% |
17,092
+4,227
| +33% | +$55.2K |
|
2678
Real REMAX Group Inc. Common Stock
REAX
$358M
| $175K | ﹤0.01% |
4,297
+365
| +9% | +$17.3K |
|
2679
Acacia Research
ACTG
$417M
| $174K | ﹤0.01% |
54,271
+872
| +2% | +$3.57K |
|
2680
The Honest Company
HNST
$568M
| $173K | ﹤0.01% |
36,794
+3,305
| +10% | +$18.9K |
|
2681
Hyliion Holdings
HYLN
$754M
| $173K | ﹤0.01% |
122,924
+1,388
| +1% | +$2.75K |
|
2682
National CineMedia
NCMI
$213M
| $173K | ﹤0.01% |
29,557
+2,808
| +10% | +$18K |
|
2683
Vera Bradley
VRA
$116M
| $173K | ﹤0.01% |
76,874
+11,000
| +17% | +$35.5K |
|
2684
Cricut
CRCT
$1.29B
| $171K | ﹤0.01% |
33,176
+708
| +2% | +$3.95K |
|
2685
KRONOS Worldwide
KRO
$950M
| $171K | ﹤0.01% |
22,804
+1,797
| +9% | +$15.8K |
|
2686
NewtekOne
NEWT
$325M
| $170K | ﹤0.01% |
14,115
| – | – |
|
2687
Phathom Pharmaceuticals
PHAT
$591M
| $170K | ﹤0.01% |
27,013
+1,372
| +5% | +$8.33K |
|
2688
Zevra Therapeutics
ZVRA
$656M
| $170K | ﹤0.01% |
22,685
+2,120
| +10% | +$16.8K |
|
2689
Pagaya Technologies
PGY
$1.47B
| $169K | ﹤0.01% |
16,060
+1,508
| +10% | +$16.7K |
|
|
SELF
2690
Global Self Storage
SELF
$57.7M
| $169K | ﹤0.01% |
33,399
| – | – |
|
2691
CorMedix
CRMD
$612M
| $165K | ﹤0.01% |
26,686
+3,241
| +14% | +$33.5K |
|
2692
Wolfspeed
WOLF
$1.46B
| $165K | ﹤0.01% |
53,760
-12,473,944
| -100% | -$72.9M |
|
2693
Beyond Meat
BYND
$144M
| $163K | ﹤0.01% |
1,778
+148
| +9% | +$16.3K |
|
2694
ClearPoint Neuro
CLPT
$452M
| $161K | ﹤0.01% |
13,500
-4,200
| -24% | -$65.3K |
|
2695
Bioventus
BVS
$943M
| $160K | ﹤0.01% |
17,409
+2,215
| +15% | +$22.1K |
|
|
IVAC
2696
DELISTED
Intevac Inc
IVAC
| $159K | ﹤0.01% |
39,700
| – | – |
|
2697
Altimmune
ALT
$595M
| $158K | ﹤0.01% |
31,478
+3,332
| +12% | +$21.1K |
|
|
LPSN
2698
DELISTED
LivePerson
LPSN
| $158K | ﹤0.01% |
13,173
| – | – |
|
2699
Pangaea Logistics
PANL
$524M
| $158K | ﹤0.01% |
33,072
+3,312
| +11% | +$17.4K |
|
2700
iHeartMedia
IHRT
$354M
| $156K | ﹤0.01% |
94,360
+3,615
| +4% | +$7.28K |
|
Similar funds
T. Rowe Price Associates's Q1 2025 Portfolio in Review
As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
- T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
- T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
- T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
- T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
- T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.
Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.